Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice

Neurotoxicology and Teratology

Volumn 39, Issue , 2013, Pages 26-35

  Lin, Zhoumeng ^a   Dodd, Celia A ^a,b   Filipov, Nikolay M ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b FORT VALLEY STATE UNIVERSITY   (United States)

Author keywords

Atrazine; Dopamine; Forced swim test; Novel object recognition test; Pesticides

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; ATRAZINE; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; HOMOVANILLIC ACID; MESSENGER RNA; MONOAMINE; NORADRENALIN; TYROSINE 3 MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORTER 2;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; CORPUS STRIATUM; DOPAMINE METABOLISM; EXPOSURE; FORCED SWIMMING TEST; HIPPOCAMPUS; LOCOMOTION; MALE; MONOAMINERGIC SYSTEM; MOTOR DYSFUNCTION; MOUSE; NEUROCHEMISTRY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OPEN FIELD TEST; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TASK PERFORMANCE;

3,4-DIHYDROXYPHENYLACETIC ACID; 3-METHOXY-4-HYDROXYPHENYLGLYCOL; 3-METHOXYTYRAMINE; 3-MT; 5-HIAA; 5-HT; 5-HYDROXYINDOLEACETIC ACID; ACETYLCHOLINE ESTERASE; ACHE; ANALYSIS OF VARIANCE; ANOVA; ATR; ATRAZINE; ATRAZINE, 2-CHLORO-4-(ETHYLAMINO)-6-(ISOPROPYLAMINO)-S-TRIAZINE; DA; DACT; DAT; DIDEALKYLATRAZINE, 2-CHLORO-4,6-DIAMINO-1,3,5-TRIAZINE; DOPAC; DOPAMINE; DOPAMINE RECEPTOR D1; DOPAMINE RECEPTOR D2; DOPAMINE RECEPTOR D4; DOPAMINE TRANSPORTER; DRD1; DRD2; DRD4; FORCED SWIM TEST; FST; HOMOVANILLIC ACID; HORSERADISH PEROXIDASE; HRP; HVA; INTRAPERITONEAL; IP; LOAEL; LOWEST OBSERVED ADVERSE EFFECT LEVEL; MHPG; N; NE; NEWTON; NOR; NOREPINEPHRINE; NOVEL OBJECT RECOGNITION TEST; NUCLEAR RECEPTOR RELATED 1; NURR1; PARKINSON'S DISEASE; PD; PESTICIDES; SEROTONIN; TH; TYROSINE HYDROXYLASE; VENTRAL TEGMENTAL AREA; VESICULAR MONOAMINE TRANSPORTER 2; VMAT-2; VTA;

ANIMALS; ATRAZINE; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HERBICIDES; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; NOREPINEPHRINE; PREFRONTAL CORTEX; RECEPTORS, DOPAMINE; SEROTONIN; TYROSINE 3-MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 84880264296     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2013.06.002     Document Type: Article

References (77)

1. Alcaro A., Huber R., Panksepp J. Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective. Brain Res Rev 2007, 56:283-321.
2. Antunes M., Biala G. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process 2012, 13:93-110.
3. Bardullas U., Limon-Pacheco J.H., Giordano M., Carrizales L., Mendoza-Trejo M.S., Rodriguez V.M. Chronic low-level arsenic exposure causes gender-specific alterations in locomotor activity, dopaminergic systems, and thioredoxin expression in mice. Toxicol Appl Pharmacol 2009, 239:169-177.
4. Bardullas U., Giordano M., Rodriguez V.M. Chronic atrazine exposure causes disruption of the spontaneous locomotor activity and alters the striatal dopaminergic system of the male Sprague-Dawley rat. Neurotoxicol Teratol 2011, 33:263-272.
5. Battaglin W.A., Rice K.C., Focazio M.J., Salmons S., Barry R.X. The occurrence of glyphosate, atrazine, and other pesticides in vernal pools and adjacent streams in Washington, DC, Maryland, Iowa, and Wyoming, 2005-2006. Environ Monit Assess 2009, 155:281-307.
6. Baudry A., Mouillet-Richard S., Launay J.M., Kellermann O. New views on antidepressant action. Curr Opin Neurobiol 2011, 21:858-865.
7. Belloni V., Dessi-Fulgheri F., Zaccaroni M., Di Consiglio E., De Angelis G., Testai E., et al. Early exposure to low doses of atrazine affects behavior in juvenile and adult CD1 mice. Toxicology 2011, 279:19-26.
8. Coban A., Filipov N.M. Dopaminergic toxicity associated with oral exposure to the herbicide atrazine in juvenile male C57BL/6 mice. J Neurochem 2007, 100:1177-1187.
9. Cooper R.L., Stoker T.E., Goldman J.M., Parrish M.B., Tyrey L. Effect of atrazine on ovarian function in the rat. Reprod Toxicol 1996, 10:257-264.
10. Cooper R.L., Stoker T.E., Tyrey L., Goldman J.M., McElroy W.K. Atrazine disrupts the hypothalamic control of pituitary-ovarian function. Toxicol Sci 2000, 53:297-307.
11. Cooper R.L., Laws S.C., Das P.C., Narotsky M.G., Goldman J.M., Lee Tyrey E., et al. Atrazine and reproductive function: mode and mechanism of action studies. Birth Defects Res B Dev Reprod Toxicol 2007, 80:98-112.
12. Curwin B.D., Hein M.J., Sanderson W.T., Striley C., Heederik D., Kromhout H., et al. Urinary pesticide concentrations among children, mothers and fathers living in farm and non-farm households in Iowa. Ann Occup Hyg 2007, 51:53-65.
13. Das P.C., McElroy W.K., Cooper R.L. Differential modulation of catecholamines by chlorotriazine herbicides in pheochromocytoma (PC12) cells in vitro. Toxicol Sci 2000, 56:324-331.
14. Das P.C., McElroy W.K., Cooper R.L. Potential mechanisms responsible for chlorotriazine-induced alterations in catecholamines in pheochromocytoma (PC12) cells. Life Sci 2003, 73:3123-3138.
15. den Hollander B., Rozov S., Linden A.M., Uusi-Oukari M., Ojanpera I., Korpi E.R. Long-term cognitive and neurochemical effects of "bath salt" designer drugs methylone and mephedrone. Pharmacol Biochem Behav 2013, 103:501-509.
16. EPA Interim Reregistration Eligibility Decision for Atrazine. Case No. 0062 2003, 15-52. Available at URL: http://www.epa.gov/oppsrrd1/REDs/atrazine_ired.pdf., U.S. Environmental Protection Agency, Washington, DC.
17. Filipov N.M., Pinchuk L.M., Boyd B.L., Crittenden P.L. Immunotoxic effects of short-term atrazine exposure in young male C57BL/6 mice. Toxicol Sci 2005, 86:324-332.
18. Filipov N.M., Stewart M.A., Carr R.L., Sistrunk S.C. Dopaminergic toxicity of the herbicide atrazine in rat striatal slices. Toxicology 2007, 232:68-78.
19. Foradori C.D., Hinds L.R., Hanneman W.H., Handa R.J. Effects of atrazine and its withdrawal on gonadotropin-releasing hormone neuroendocrine function in the adult female Wistar rat. Biol Reprod 2009, 81:1099-1105.
20. Foradori C.D., Hinds L.R., Hanneman W.H., Legare M.E., Clay C.M., Handa R.J. Atrazine inhibits pulsatile luteinizing hormone release without altering pituitary sensitivity to a gonadotropin-releasing hormone receptor agonist in female Wistar rats. Biol Reprod 2009, 81:40-45.
21. Foradori C.D., Zimmerman A.D., Hinds L.R., Zuloaga K.L., Breckenridge C.B., Handa R.J. Atrazine inhibits pulsatile gonadotropin-releasing hormone (GnRH) release without altering GnRH messenger RNA or protein levels in the female rat. Biol Reprod 2013, 88:1-7.
22. Fraites M.J., Cooper R.L., Buckalew A., Jayaraman S., Mills L., Laws S.C. Characterization of the hypothalamic-pituitary-adrenal axis response to atrazine and metabolites in the female rat. Toxicol Sci 2009, 112:88-99.
23. Fraites M.J., Narotsky M.G., Best D.S., Stoker T.E., Davis L.K., Goldman J.M., et al. Gestational atrazine exposure: effects on male reproductive development and metabolite distribution in the dam, fetus, and neonate. Reprod Toxicol 2011, 32:52-63.
24. Gatto N.M., Cockburn M., Bronstein J., Manthripragada A.D., Ritz B. Well-water consumption and Parkinson's disease in rural California. Environ Health Perspect 2009, 117:1912-1918.
25. Gordon J.A., Hen R. The serotonergic system and anxiety. Neuromolecular Med 2004, 5:27-40.
26. Hanioka N., Jinno H., Tanaka-Kagawa T., Nishimura T., Ando M. Changes in rat liver cytochrome P450 enzymes by atrazine and simazine treatment. Xenobiotica 1998, 28:683-698.
27. Hata T., Itoh E., Nishikawa H. Behavioral characteristics of SART-stressed mice in the forced swim test and drug action. Pharmacol Biochem Behav 1995, 51:849-853.
28. Hata T., Nishikawa H., Itoh E., Watanabe A. Depressive state with anxiety in repeated cold-stressed mice in forced swimming tests. Jpn J Pharmacol 1999, 79:243-249.
29. Hoebel B.G., Avena N.M., Rada P. An accumbens dopamine-acetylcholine system for approach and avoidance. Handbook of approach and avoidance motivation 2008, 89-108. Taylor & Francis Group, New York. A.J. Elliot (Ed.).
30. Hossain M.M., Filipov N.M. Alteration of dopamine uptake into rat striatal vesicles and synaptosomes caused by an in vitro exposure to atrazine and some of its metabolites. Toxicology 2008, 248:52-58.
31. Hotchkiss M.G., Best D.S., Cooper R.L., Laws S.C. Atrazine does not induce pica behavior at doses that increase hypothalamic-pituitary-adrenal axis activation and cause conditioned taste avoidance. Neurotoxicol Teratol 2012, 34:295-302.
32. Karrow N.A., McCay J.A., Brown R.D., Musgrove D.L., Guo T.L., Germolec D.R., et al. Oral exposure to atrazine modulates cell-mediated immune function and decreases host resistance to the B16F10 tumor model in female B6C3F1 mice. Toxicology 2005, 209:15-28.
33. Krutz L.J., Shaner D.L., Zablotowicz R.M. Enhanced degradation and soil depth effects on the fate of atrazine and major metabolites in Colorado and Mississippi soils. J Environ Qual 2010, 39:1369-1377.
34. LeBaron H.M., MacFarland J.E., Burnside O.C. The triazine herbicides 50 years revolutionizing agriculture 2008, 1-44m. Elsevier, Amsterdam.
35. Li Y., Li S., Wei C., Wang H., Sui N., Kirouac G.J. Changes in emotional behavior produced by orexin microinjections in the paraventricular nucleus of the thalamus. Pharmacol Biochem Behav 2010, 95:121-128.
36. Lin Z., Dodd C.A., Filipov N.M. Differentiation state-dependent effects of in vitro exposure to atrazine or its metabolite diaminochlorotriazine in a dopaminergic cell line. Life Sci 2013, 92:81-90.
37. Litteljohn D., Mangano E., Shukla N., Hayley S. Interferon-gamma deficiency modifies the motor and co-morbid behavioral pathology and neurochemical changes provoked by the pesticide paraquat. Neuroscience 2009, 164:1894-1906.
38. Lotharius J., Brundin P. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci 2002, 3:932-942.
39. Lozier M.J., Curwin B., Nishioka M.G., Sanderson W. Determinants of atrazine contamination in the homes of commercial pesticide applicators across time. J Occup Environ Hyg 2012, 9:289-297.
40. Matsuura K., Kabuto H., Makino H., Ogawa N. Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J Neurosci Methods 1997, 73:45-48.
41. Middlemore-Risher M.L., Buccafusco J.J., Terry A.V. Repeated exposures to low-level chlorpyrifos results in impairments in sustained attention and increased impulsivity in rats. Neurotoxicol Teratol 2010, 32:415-424.
42. Miller G., Neilan M., Chia R., Gheryani N., Holt N., Charbit A., et al. ENU mutagenesis reveals a novel phenotype of reduced limb strength in mice lacking fibrillin 2. PLoS One 2010, 5:e9137.
43. Montgomery K.C. The relation between fear induced by novel stimulation and exploratory behavior. J Comp Physiol Psychol 1955, 48:254-260.
44. Morley K.C., Gallate J.E., Hunt G.E., Mallet P.E., McGregor I.S. Increased anxiety and impaired memory in rats 3months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy"). Eur J Pharmacol 2001, 433:91-99.
45. Mosquin P., Whitmore R.W., Chen W. Estimation of upper centile concentrations using historical atrazine monitoring data from community water systems. J Environ Qual 2012, 41:834-844.
46. Nelson A.J., Thur K.E., Marsden C.A., Cassaday H.J. Dissociable roles of dopamine within the core and medial shell of the nucleus accumbens in memory for objects and place. Behav Neurosci 2010, 124:789-799.
47. NIH Guide for the care and use of laboratory animals 2011, 1-220. National Research Council, Washington, D.C. 8th ed.
48. Nowak P., Dabrowska J., Bortel A., Izabela B., Kostrzewa R.M., Brus R. Prenatal cadmium and ethanol increase amphetamine-evoked dopamine release in rat striatum. Neurotoxicol Teratol 2006, 28:563-572.
49. O'Shea M., Singh M.E., McGregor I.S., Mallet P.E. Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. J Psychopharmacol 2004, 18:502-508.
50. Page M.E., Brown K., Lucki I. Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action. Psychopharmacology (Berl) 2003, 165:194-201.
51. Perez V.P., de Lima M.N., da Silva R.S., Dornelles A.S., Vedana G., Bogo M.R., et al. Iron leads to memory impairment that is associated with a decrease in acetylcholinesterase pathways. Curr Neurovasc Res 2010, 7:15-22.
52. Perona M.T., Waters S., Hall F.S., Sora I., Lesch K.P., Murphy D.L., et al. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behav Pharmacol 2008, 19:566-574.
53. Petit-Demouliere B., Chenu F., Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl) 2005, 177:245-255.
54. Pogrmic-Majkic K., Kaisarevic S., Fa S., Dakic V., Glisic B., Hrubik J., et al. Atrazine effects on antioxidant status and xenobiotic metabolizing enzymes after oral administration in peripubertal male rat. Environ Toxicol Pharmacol 2012, 34:495-501.
55. Ramos A., Mormede P. Stress and emotionality: a multidimensional and genetic approach. Neurosci Biobehav Rev 1998, 22:33-57.
56. Rodriguez V.M., Thiruchelvam M., Kochar J., Cory-Slechta D.A. Atrazine exposure causes alterations in the nigrostriatal and mesostriatal systems in the rat. Toxicol (Suppl Toxicol Sci) 2007, 188:910. [Abstract].
57. Rodriguez V.M., Limon-Pacheco J.H., Mendoza-Trejo M.S., Gonzalez-Gallardo A., Hernandez-Plata I., Giordano M. Repeated exposure to the herbicide atrazine alters locomotor activity and the nigrostriatal dopaminergic system of the albino rat. Neurotoxicology 2013, 34:82-94.
58. Roecker R., Junges G.M., de Lima D.D., Delwing F., Wyse A.T.S., Cruz J.N., et al. Prolonged acetylcholinesterase inhibition and impairment in object recognition memory in rats subjected to chronic hyperprolinemia. Biol Med 2012, 4:126-133.
59. Ross M.K., Filipov N.M. Determination of atrazine and its metabolites in mouse urine and plasma by LC-MS analysis. Anal Biochem 2006, 351:161-173.
60. Ross M.K., Jones T.L., Filipov N.M. Disposition of the herbicide 2-chloro-4-(ethylamino)-6-(isopropylamino)-s-triazine (Atrazine) and its major metabolites in mice: a liquid chromatography/mass spectrometry analysis of urine, plasma, and tissue levels. Drug Metab Dispos 2009, 37:776-786.
61. Royl G., Balkaya M., Lehmann S., Lehnardt S., Stohlmann K., Lindauer U., et al. Effects of the PDE5-inhibitor vardenafil in a mouse stroke model. Brain Res 2009, 1265:148-157.
62. Schultz W. Multiple dopamine functions at different time courses. Annu Rev Neurosci 2007, 30:259-288.
63. Shaw G. New evidence for association of pesticides with Parkinson disease. Neurol Today 2011, 11(1):16-21.
64. Sik A., van Nieuwehuyzen P., Prickaerts J., Blokland A. Performance of different mouse strains in an object recognition task. Behav Brain Res 2003, 147:49-54.
65. Singh M., Sandhir R., Kiran R. Effects on antioxidant status of liver following atrazine exposure and its attenuation by vitamin E. Exp Toxicol Pathol 2011, 63:269-276.
66. Smidt M.P., Smits S.M., Burbach J.P. Molecular mechanisms underlying midbrain dopamine neuron development and function. Eur J Pharmacol 2003, 480:75-88.
67. Speed H.E., Blaiss C.A., Kim A., Haws M.E., Melvin N.R., Jennings M., et al. Delayed reduction of hippocampal synaptic transmission and spines following exposure to repeated subclinical doses of organophosphorus pesticide in adult mice. Toxicol Sci 2012, 125:196-208.
68. Stranahan A.M., Arumugam T.V., Cutler R.G., Lee K., Egan J.M., Mattson M.P. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci 2008, 11:309-317.
69. Taylor T.N., Greene J.G., Miller G.W. Behavioral phenotyping of mouse models of Parkinson's disease. Behav Brain Res 2010, 211:1-10.
70. Ugazio G., Bosio A., Burdino E., Ghigo L., Nebbia C. Lethality, hexobarbital narcosis and behavior in rats exposed to atrazine, bentazon or molinate. Res Commun Chem Pathol Pharmacol 1991, 74:349-361.
71. Wallace M., Frankfurt M., Arellanos A., Inagaki T., Luine V. Impaired recognition memory and decreased prefrontal cortex spine density in aged female rats. Ann N Y Acad Sci 2007, 1097:54-57.
72. Weiss J.M., Goodman P.A., Losito B.G., Corrigan S., Charry J.M., Bailey W.H. Behavioral depression produced by an uncontrollable stressor: relationship to norepinephrine, dopamine, and serotonin levels in various regions of rat brain. Brain Res Rev 1981, 3:167-205.
73. West A.P. Neurobehavioral studies of forced swimming: the role of learning and memory in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry 1990, 14:863-877.
74. Xing H., Han Y., Li S., Wang J., Wang X., Xu S. Alterations in mRNA expression of acetylcholinesterase in brain and muscle of common carp exposed to atrazine and chlorpyrifos. Ecotoxicol Environ Saf 2010, 73:1666-1670.
75. Xing H., Wang J., Li J., Fan Z., Wang M., Xu S. Effects of atrazine and chlorpyrifos on acetylcholinesterase and carboxylesterase in brain and muscle of common carp. Environ Toxicol Pharmacol 2010, 30:26-30.
76. Xing H., Li S., Wang Z., Gao X., Xu S., Wang X. Histopathological changes and antioxidant response in brain and kidney of common carp exposed to atrazine and chlorpyrifos. Chemosphere 2012, 88:377-383.
77. Yi L.T., Li Y.C., Pan Y., Li J.M., Xu Q., Mo S.F., et al. Antidepressant-like effects of psoralidin isolated from the seeds of Psoralea corylifolia in the forced swimming test in mice. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:510-519.